跳至主要内容
临床试验/CTRI/2018/01/011120
CTRI/2018/01/011120尚未招募2 期

Pharmaceutical standardization of two different dosages forms of Aragvadhadi Taila and their comparative efficacy in the management of Shvitra (Vitiligo)

Institute for Post Graduate Teaching and Research in Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients having signs and symptoms of Shvitra (vitiligo).
  • 2. Patient between the age-18 to 60 years.
  • 3. Patients with chronicity of less than 10 years

排除标准

  • 1. Patients with Chronicity more than 10 years.
  • 2. Patients having serious cardiac, renal, hepatic diseases, major illness like IDDM, NIDDM, patches due to burning, chemical explosion, any other serious systemic illness.
  • 3. Gravid and lactating women.
  • Women in fertile age planning for conception within next 3 months.
  • Cases with Asadhya Lakshana of Shvitra

研究者

发起方
Institute for Post Graduate Teaching and Research in Ayurveda

相似试验